Dhingra K - Search Results

1

Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis.

Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, Hortobagyi G, Lippman SM, Dhingra K, Lotan R. Xu XC, et al. Among authors: dhingra k. Cancer Res. 1997 Nov 15;57(22):4992-6. Cancer Res. 1997. PMID: 9371489

2

Sialyl-Tn antigen expression occurs early during human mammary carcinogenesis and is associated with high nuclear grade and aneuploidy.

Cho SH, Sahin A, Hortobagyi GN, Hittelman WN, Dhingra K. Cho SH, et al. Among authors: dhingra k. Cancer Res. 1994 Dec 15;54(24):6302-5. Cancer Res. 1994. PMID: 7987817

3

Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections.

Chen T, Dhingra K, Sahin A, Sneige N, Hortobagyi G, Aldaz CM. Chen T, et al. Among authors: dhingra k. Breast Cancer Res Treat. 1996;39(2):177-85. doi: 10.1007/BF01806184. Breast Cancer Res Treat. 1996. PMID: 8872326

4

Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism.

Dhingra K, Sahin A, Emami K, Hortobagyi GN, Estrov Z. Dhingra K, et al. Breast Cancer Res Treat. 1998 Mar;48(2):165-74. doi: 10.1023/a:1005942923757. Breast Cancer Res Treat. 1998. PMID: 9596488

5

Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast.

Hoque A, Lippman SM, Boiko IV, Atkinson EN, Sneige N, Sahin A, Weber DM, Risin S, Lagios MD, Schwarting R, Colburn WJ, Dhingra K, Follen M, Kelloff GJ, Boone CW, Hittelman WN. Hoque A, et al. Among authors: dhingra k. Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):249-59. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11303595

6

Chromosome in situ hybridization on formalin-fixed mammary tissue using non-isotopic, non-fluorescent probes: technical considerations and biological implications.

Dhingra K, Sahin A, Supak J, Kim SY, Hortobagyi G, Hittelman WN. Dhingra K, et al. Breast Cancer Res Treat. 1992;23(3):201-10. doi: 10.1007/BF01833516. Breast Cancer Res Treat. 1992. PMID: 1463859

7

Genetic changes in breast cancer--consequences for therapy?

Dhingra K, Hittelman WN, Hortobagyi GN. Dhingra K, et al. Gene. 1995 Jun 14;159(1):59-63. doi: 10.1016/0378-1119(94)00560-f. Gene. 1995. PMID: 7607573 Review.

8

Quantitative analysis of chromosome in situ hybridization signal in paraffin-embedded tissue sections.

Dhingra K, Sneige N, Pandita TK, Johnston DA, Lee JS, Emami K, Hortobagyi GN, Hittelman WN. Dhingra K, et al. Cytometry. 1994 Jun 1;16(2):100-12. doi: 10.1002/cyto.990160203. Cytometry. 1994. PMID: 7924678 Free article.

9

Strategies for the application of biomarkers for risk assessment and efficacy in breast cancer chemoprevention trials.

Dhingra K, Vogel V, Sneige N, Sahin A, Aldaz CM, Hortobagyi GN, Hittelman W. Dhingra K, et al. J Cell Biochem Suppl. 1993;17G:37-43. doi: 10.1002/jcb.240531106. J Cell Biochem Suppl. 1993. PMID: 8007707 Review.

10

Phase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanoma.

Dhingra K, Papadopoulos N, Lippman S, Lotan R, Legha SS. Dhingra K, et al. Invest New Drugs. 1993 Feb;11(1):39-43. doi: 10.1007/BF00873908. Invest New Drugs. 1993. PMID: 8349434 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters